Trials / Recruiting
RecruitingNCT07299097
Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Takeda · Industry
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to find out how many people in Spain have been diagnosed with narcolepsy type 1 and type 2, and how many new participants are diagnosed each year. Narcolepsy is a rare sleep disorder that causes excessive daytime sleepiness. The researchers will look at medical records from hospitals across Spain to count participants with these conditions and understand patterns in diagnosis over time.
Detailed description
The aim is to do epidemiology study in the core group thus the enrolment number is not applicable to this group, however approximately100 participants in the supplementary group (online survey).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | As this is an observational study, no intervention will be administered. |
Timeline
- Start date
- 2025-12-02
- Primary completion
- 2026-05-30
- Completion
- 2026-05-30
- First posted
- 2025-12-23
- Last updated
- 2026-03-05
Locations
10 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT07299097. Inclusion in this directory is not an endorsement.